Related Experiment Video
Updated: Jul 16, 2025

A Psychophysics Paradigm for the Collection and Analysis of Similarity Judgments
Published on: March 1, 2022
Multivariate Exact Discrepancy: A New Tool for PK/PD Model Evaluation.
Sarah Baklouti1,2, Emmanuelle Comets3,4, Peggy Gandia1,2
1Laboratoire de Pharmacocinétique et Toxicologie, Institut Fédératif de Biologie, CHU de Toulouse, Toulouse, France.
This study introduces a new method for evaluating pharmacokinetic models, addressing limitations in current approaches for analyzing dependent concentration data within individuals. The method assigns a probability score to assess model fit for each patient, aiding in model selection for therapeutic drug monitoring.
Area of Science:
- Pharmacometrics
- Pharmacokinetic modeling
- Statistical analysis
Background:
- Pharmacokinetic (PK) models are crucial for drug development and therapeutic drug monitoring.
- Current evaluation metrics, such as Visual Predictive Check (VPC) and Normalised Prediction Distribution Error (NPDE), have limitations, particularly with dependent concentration data from the same patient.
- There is a need for improved methods to accurately assess PK model performance in complex scenarios.
Purpose of the Study:
- To propose a novel evaluation method for pharmacokinetic models that explicitly accounts for the dependency between concentration measurements within an individual.
- To provide a robust approach for assessing model fit and identifying potential issues in PK model development.
- To facilitate the selection of appropriate models for therapeutic drug monitoring.
Main Methods:
- The proposed method analyzes the distribution of simulated concentration vectors to generate an individual probability score.
- This score reflects the likelihood that an individual's observed concentrations originate from the studied PK model.
- Aggregate analysis of these individual probabilities allows for a comprehensive evaluation of the overall model performance.
Main Results:
- The method's effectiveness was demonstrated through two illustrative examples.
- The approach successfully identified structural model misspecifications.
- Outlier kinetics within datasets were effectively detected, highlighting the method's sensitivity.
Conclusions:
- A straightforward and effective method for evaluating PK models during development has been presented.
- The method shows promise for selecting optimal models for therapeutic drug monitoring.
- Further validation on a larger scale is recommended to confirm the method's broad applicability and robustness.
Related Concept Videos
One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation
On...
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Mechanistic Models: Compartment Models in Individual and Population Analysis
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Variability: Analysis
The range is a simple measure of variability, indicating the difference between the highest and...
Variation
When independent and dependent variables are plotted on a scatter plot, the slope of a line is a value that describes the rate of change between the two...

